Binbin Cui
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- Dialysis and Renal Disease Management
Papers in
-
- Ubiquitin and proteasome pathways 3
- Metabolomics and Mass Spectrometry Studies 2
- Oncology 8
- Colorectal Cancer Treatments and Studies 3
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Yanlong Liu (4 shared papers)Yanmei Yang (3 shared papers)Peng Han (4 shared papers)Shougang Zhuang (5 shared papers)Yongmin Li (3 shared papers)Xinshu Dong (2 shared papers)Tao Ji (2 shared papers)Fulan Hu (1 shared paper)
- Journals
- Tumor Biology (2 papers)Oncotarget (2 papers)PLoS ONE (2 papers)Renal Failure (1 paper)Metabolomics (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Binbin Cui
19 papers receiving 335 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 123
- Nephrology 34
- Oncology 87
- Molecular Biology 197
- Biotechnology 15
Countries citing papers authored by Binbin Cui
This map shows the geographic impact of Binbin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binbin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binbin Cui more than expected).
Fields of papers citing papers by Binbin Cui
This network shows the impact of papers produced by Binbin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binbin Cui. The network helps show where Binbin Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Binbin Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. | 2015 | 42 |
| 2 | 2022 | 38 | |
| 3 | 2017 | 29 | |
| 4 | 2016 | 26 | |
| 5 | 2020 | 24 | |
| 6 | 2018 | 24 | |
| 7 | 2011 | 24 | |
| 8 | 2018 | 21 | |
| 9 | 2021 | 19 | |
| 10 | 2021 | 17 | |
| 11 | 2015 | 17 | |
| 12 | 2011 | 14 | |
| 13 | 2017 | 9 | |
| 14 | 2012 | 8 | |
| 15 | 2014 | 8 | |
| 16 | Abnormal expression of p190RhoGAP in colorectal cancer patients with poor survival. | 2016 | 8 |
| 17 | 2022 | 6 | |
| 18 | 2014 | 5 | |
| 19 | 2021 | 1 | |
| 20 | 2025 | 0 |
About Binbin Cui
Binbin Cui is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 20 papers that have together received 340 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer Cells and Metastasis (3 papers), Cancer-related Molecular Pathways (3 papers), Ubiquitin and proteasome pathways (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Cancer-related molecular mechanisms research (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Cancer Research (123 citations), Nephrology (34 citations), Oncology (87 citations), Molecular Biology (197 citations) and Biotechnology (15 citations). Binbin Cui has collaborated with scholars based in China and United States. Frequent co-authors include Yanlong Liu, Yanmei Yang, Peng Han, Shougang Zhuang, Yongmin Li, Xinshu Dong, Tao Ji, Fulan Hu, Wangyang Chen and Feng Liu. Their work appears in journals such as Tumor Biology, Oncotarget, PLoS ONE, Renal Failure and Metabolomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.